What the Neulasta Onpro TV commercial - Rather Be Home - FN is about.
The Neulasta Onpro TV Spot, 'Rather Be Home - FN' is a commercial that promotes a medical device that helps cancer patients reduce the risk of infection after chemotherapy. The TV spot features a middle-aged woman named Diane who is undergoing chemotherapy as part of cancer treatment.
The commercial begins with Diane waking up in a hospital bed, surrounded by medical professionals. She expresses her desire to go home and is worried about the risk of infection and the need for daily injections after chemo. The healthcare provider then assures her that the Neulasta Onpro device can help her reduce her risk of infection and avoid the need for additional injections.
The device is a small, disposable, pre-filled syringe that automatically delivers medication after chemotherapy. The device is attached to the patient's arm and can be easily removed while at home. This can help reduce the need for hospital visits and long hours of waiting at the clinic.
The commercial then shows Diane back at home, spending quality time with her loved ones, eating her favorite foods, and enjoying comfortable surroundings. The voiceover emphasizes that with the Neulasta Onpro device, cancer patients like Diane can get the protection they need, without sacrificing the comfort of staying at home.
Overall, the TV spot is emotional and impactful, highlighting the benefits of the Neulasta Onpro device for cancer patients and their families. The commercial showcases how this device can help improve the quality of life for patients during their cancer treatment, ultimately making their battle with cancer a little less daunting.
Neulasta Onpro TV commercial - Rather Be Home - FN produced for
Neulasta
was first shown on television on May 21, 2017.
Frequently Asked Questions about neulasta onpro tv spot, 'rather be home - fn'
Neulasta® is a prescription medicine used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid), who receive anti-cancer medicines (chemotherapy) that can cause fever and low white blood cell count.
Neulasta® Onpro® helps protect you from febrile neutropenia
For more than 15 years, Neulasta® has been used to help reduce the risk of infection resulting from strong chemotherapy. Today, most patients use Neulasta® Onpro® to receive their Neulasta® dose at home instead of having to go back to the doctor's office.*
The Neulasta patch, called Neulasta Onpro, is applied by a healthcare professional right after your chemotherapy infusion. The patch automatically delivers the dose of Neulasta over 45 minutes, approximately 27 hours after the patch is applied. Once the dose is complete, you remove the patch.
Your spleen may become enlarged and can rupture while taking Neulasta®. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or left shoulder tip area. A serious lung problem called Acute Respiratory Distress Syndrome (ARDS).
Neulasta® Onpro™ kit: Leave the medicine in the carton until you are ready to use it. You may let the medicine warm up to room temperature before you use it. Keep it away from heat or direct light. The medicine can stay out of the refrigerator for up to 12 hours.
Neulasta Alternatives Compared
Neulasta (pegfilgrastim) | Neupogen (filgrastim) | Filgrastim |
---|
Brand Names |
Other pegfilgrastim brands include: Fulphila, Fylnetra, Nyvepria, Stimufend, Udenyca, Ziextenzo | Other filgrastim brands include: Nivestym, Releuko, Zarxio | Neupogen, Nivestym, Releuko, Zarxio |
Neulasta is a prescription medicine used to prevent neutropenia (a lack of certain white blood cells) that is caused by receiving chemotherapy. Neulasta helps reduce the chance of infections.
What Is Neulasta? Neulasta (pegfilgrastim) is a colony-stimulating factor, a man-made form of a protein that stimulates the growth of white blood cells, used to decrease the incidence of infection, by treating neutropenia, a lack of certain white blood cells caused by receiving cancer chemotherapy.
The on-body injector is designed to automatically deliver your Neulasta® dose over 45 minutes, approximately 27 hours after application. Once your dose is complete, remove the injector and dispose of it according to the Patient Instructions for Use.
Neulasta is a long lasting medication so blood levels slowly decrease over approximately 2 weeks.
Neulasta is a man-made form of granulocyte colony-stimulating factor (G-CSF), which is made using the bacteria Escherichia coli. G-CSF is a substance produced by the body. It stimulates the growth of neutrophils (nu-tro-fils), a type of white blood cell important in the body's fight against infection.
Keep this medicine in its original container until you are ready to use it. You may store it at room temperature for up to 5 days, and if not used can be returned to the refrigerator. Throw away any unused medicine that has been left at room temperature for more than 5 days.